Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice
Carla Boquimpani; Fernanda Salles Seguro; Gustavo Henrique Romani Magalhães; Ingrid Luise Soares Pinto; Israel Bendit; Jaisson André Pagnoncelli Bortolini; Katia Borgia Barbosa Pagnano; Renato Centrone; Vaneuza Funke;
Hematol Transfus Cell Ther. 2022;44:402-9
Fulminant hepatitis secondary to nivolumab in a patient with Hodgkin¿s Lymphoma after complete remission
Ana Júlia Negrelli dos Santos; Arthur Gomes Oliveira Braga; Talita Maira Bueno da Silveira;
10.1016/j.htct.2025.103983
REVERSAL OF ACCELERATED PHASE CML WITH HIGH BLAST COUNT FOLLOWING 5+2 CHEMOTHERAPY AND DASATINIB: A CASE REPORT
Bü¿ra Akdo¿an; Ali Turunç; Birol Güvenç;
Hematol Transfus Cell Ther. 2025;47 Supl 2: